{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T20:45:30Z","timestamp":1778705130943,"version":"3.51.4"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004410","name":"T\u00fcrkiye Bilimsel ve Teknolojik Ara\u015ft\u0131rma Kurumu","doi-asserted-by":"publisher","award":["118C312"],"award-info":[{"award-number":["118C312"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bmc.2025.118343","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T23:22:39Z","timestamp":1754954559000},"page":"118343","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Antiviral activities of phenylalanine derivatives carrying carboxylic acid bioisosteres against chikungunya and parainfluenza virus type 3"],"prefix":"10.1016","volume":"130","author":[{"given":"Merve Camc\u0131","family":"Eren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00f6rkem","family":"G\u00fcng\u00f6r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"De Jonghe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"Jochmans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet","family":"\u00d6zbil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Neyts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"Kaptein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Halil","family":"\u015eenol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aytekin","family":"K\u00f6se","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikail Hakan","family":"Gezginci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nilg\u00fcn","family":"Karal\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2025.118343_bb0005","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ijbiomac.2021.01.076","article-title":"Trends and strategies to combat viral infections: a review on FDA approved antiviral drugs","volume":"172","author":"Tompa","year":"2021","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.bmc.2025.118343_bb0010","article-title":"Comparative overview of emerging RNA viruses: epidemiology, pathogenesis, diagnosis and current treatment","volume":"79","author":"Chakrabartty","year":"2022","journal-title":"Ann Med Surg (Lond)"},{"issue":"3","key":"10.1016\/j.bmc.2025.118343_bb0015","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/ilar\/ilx026","article-title":"Are RNA viruses candidate agents for the next global pandemic? A review","volume":"58","author":"Carrasco-Hernandez","year":"2017","journal-title":"ILAR J"},{"issue":"1","key":"10.1016\/j.bmc.2025.118343_bb0020","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.antiviral.2008.01.004","article-title":"Molecular strategies to inhibit the replication of RNA viruses","volume":"78","author":"Leyssen","year":"2008","journal-title":"Antivir Res"},{"issue":"1","key":"10.1016\/j.bmc.2025.118343_bb0025","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.antiviral.2007.10.003","article-title":"Potential of antiviral therapy and prophylaxis for controlling RNA viral infections of livestock","volume":"78","author":"Goris","year":"2008","journal-title":"Antivir Res"},{"key":"10.1016\/j.bmc.2025.118343_bb0030","doi-asserted-by":"crossref","DOI":"10.1177\/20587384211002621","article-title":"A review: mechanism of action of antiviral drugs","volume":"35","author":"Kausar","year":"2021","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.bmc.2025.118343_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.131756","article-title":"RdRp (RNA-dependent RNA polymerase): A key target providing anti-virals for the management of various viral diseases","author":"Pathania","year":"2022","journal-title":"J Mol Struct"},{"issue":"1","key":"10.1016\/j.bmc.2025.118343_bb0040","article-title":"The first FDA-approved vaccine to prevent disease caused by chikungunya virus infection","volume":"15","author":"Ixchiq","year":"2024","journal-title":"Virulence"},{"issue":"7","key":"10.1016\/j.bmc.2025.118343_bb0045","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00649-20","article-title":"Novel class of chikungunya virus small molecule inhibitors that targets the viral capping machinery","volume":"64","author":"Abdelnabi","year":"2020","journal-title":"Antimicrobial Agents Chemother"},{"issue":"1","key":"10.1016\/j.bmc.2025.118343_bb0050","doi-asserted-by":"crossref","DOI":"10.1038\/srep24138","article-title":"A dual drug regimen synergistically blocks human parainfluenza virus infection","volume":"6","author":"Bailly","year":"2016","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.bmc.2025.118343_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/v13071307","article-title":"Antivirals against the chikungunya virus","volume":"13","author":"Battisti","year":"2021","journal-title":"Viruses"},{"issue":"16","key":"10.1016\/j.bmc.2025.118343_bb0060","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1016\/j.bmc.2019.06.038","article-title":"Green synthesis, biological evaluation, molecular docking studies and 3D-QSAR analysis of novel phenylalanine linked quinazoline-4(3H)-one-sulphonamide hybrid entities distorting the malarial reductase activity in folate pathway","volume":"27","author":"Patel","year":"2019","journal-title":"Bioorg Med Chem"},{"issue":"1","key":"10.1016\/j.bmc.2025.118343_bb0065","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0968-0896(00)00235-2","article-title":"N-(Hydroxyaminocarbonyl)phenylalanine: a novel class of inhibitor for carboxypeptidase a","volume":"9","author":"Chung","year":"2001","journal-title":"Bioorg Med Chem"},{"issue":"4","key":"10.1016\/j.bmc.2025.118343_bb0070","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/j.bmc.2007.10.092","article-title":"Phenylalanine-containing hydroxamic acids as selective inhibitors of class IIb histone deacetylases (HDACs)","volume":"16","author":"Schafer","year":"2008","journal-title":"Bioorg Med Chem"},{"issue":"17","key":"10.1016\/j.bmc.2025.118343_bb0075","doi-asserted-by":"crossref","first-page":"6390","DOI":"10.1016\/j.bmc.2009.07.021","article-title":"3-substituted phenylalanines as selective AMPA- and kainate receptor ligands","volume":"17","author":"Szymanska","year":"2009","journal-title":"Bioorg Med Chem"},{"issue":"18","key":"10.1016\/j.bmc.2025.118343_bb0080","doi-asserted-by":"crossref","first-page":"5679","DOI":"10.1016\/j.bmc.2013.07.034","article-title":"Synthesis and biological evaluation of novel benzyl-substituted (S)-phenylalanine derivatives as potent dipeptidyl peptidase 4 inhibitors","volume":"21","author":"Liu","year":"2013","journal-title":"Bioorg Med Chem"},{"issue":"19","key":"10.1016\/j.bmc.2025.118343_bb0085","doi-asserted-by":"crossref","first-page":"5368","DOI":"10.1016\/j.bmc.2014.07.045","volume":"22","author":"Skold","year":"2014","journal-title":"Bioorg Med Chem"},{"issue":"23","key":"10.1016\/j.bmc.2025.118343_bb0090","doi-asserted-by":"crossref","first-page":"7353","DOI":"10.1016\/j.bmc.2015.10.009","article-title":"Carbonic anhydrase inhibitors: design, synthesis, kinetic, docking and molecular dynamics analysis of novel glycine and phenylalanine sulfonamide derivatives","volume":"23","author":"Fidan","year":"2015","journal-title":"Bioorg Med Chem"},{"issue":"12","key":"10.1016\/j.bmc.2025.118343_bb0095","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1016\/j.bmc.2017.03.065","article-title":"Synthesis and biological evaluation of N-(carbobenzyloxy)-l-phenylalanine and N-(carbobenzyloxy)-l-aspartic acid-beta-benzyl ester derivatives as potent topoisomerase IIalpha inhibitors","volume":"25","author":"Han","year":"2017","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"10.1016\/j.bmc.2025.118343_bb0100","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.bbrc.2020.04.096","article-title":"N-p-Tosyl-L-phenylalanine chloromethyl ketone (TPCK) inhibits HIV-1 by suppressing the activity of viral protease","volume":"527","author":"Trivedi","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"issue":"15","key":"10.1016\/j.bmc.2025.118343_bb0105","doi-asserted-by":"crossref","first-page":"7388","DOI":"10.1016\/j.bmc.2008.06.015","article-title":"Design, synthesis, and evaluation of 3C protease inhibitors as anti-enterovirus 71 agents","volume":"16","author":"Kuo","year":"2008","journal-title":"Bioorg Med Chem"},{"issue":"8","key":"10.1016\/j.bmc.2025.118343_bb0110","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1128\/JVI.01123-12","article-title":"3C protease of enterovirus 68: structure-based design of Michael acceptor inhibitors and their broad-spectrum antiviral effects against picornaviruses","volume":"87","author":"Tan","year":"2013","journal-title":"J Virol"},{"issue":"14","key":"10.1016\/j.bmc.2025.118343_bb0115","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1016\/j.bmcl.2016.05.036","article-title":"Design, synthesis, and biological evaluation of anti-EV71 agents","volume":"26","author":"Li","year":"2016","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2025.118343_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.116010","article-title":"Design, synthesis, and lead optimization of piperazinyl-pyrimidine analogues as potent small molecules targeting the viral capping machinery of chikungunya virus","volume":"264","author":"Battisti","year":"2024","journal-title":"Eur J Med Chem"},{"issue":"22","key":"10.1016\/j.bmc.2025.118343_bb0125","doi-asserted-by":"crossref","first-page":"7902","DOI":"10.1021\/jm100762r","article-title":"Nitrile-containing pharmaceuticals: efficacious roles of the nitrile pharmacophore","volume":"53","author":"Fleming","year":"2010","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118343_bb0130","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.antiviral.2017.01.002","article-title":"Inhibition of enterovirus 71 replication by an alpha-hydroxy-nitrile derivative NK-1.9k","volume":"141","author":"Wang","year":"2017","journal-title":"Antivir Res"},{"issue":"4","key":"10.1016\/j.bmc.2025.118343_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2019.126906","article-title":"Design, synthesis, and evaluation of novel 4-amino-2-(4-benzylpiperazin-1-yl)methylbenzonitrile compounds as Zika inhibitors","volume":"30","author":"Wang","year":"2020","journal-title":"Bioorg Med Chem Lett"},{"issue":"10","key":"10.1016\/j.bmc.2025.118343_bb0140","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.2174\/138161208784139675","article-title":"Recent developments in the chemistry and in the biological applications of amidoximes","volume":"14","author":"Fylaktakidou","year":"2008","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.bmc.2025.118343_bb0145","series-title":"C., inventor; ANTIVIRAL THIAZOLO 5,4-B PYRIDINE COMPOUNDS. patent 4,443,606. patent application 388,856","author":"Wei","year":"1982"},{"issue":"13","key":"10.1016\/j.bmc.2025.118343_bb0150","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1021\/jm980103g","article-title":"Nonsymmetric P2\/P2\u2019 cyclic urea HIV protease inhibitors. Structure-activity relationship, bioavailability, and resistance profile of monoindazole-substituted P2 analogues","volume":"41","author":"De Lucca","year":"1998","journal-title":"J Med Chem"},{"issue":"15","key":"10.1016\/j.bmc.2025.118343_bb0155","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1016\/j.bmcl.2004.05.036","article-title":"Synthesis and antiviral activity of P1\u2019 arylsulfonamide azacyclic urea HIV protease inhibitors","volume":"14","author":"Huang","year":"2004","journal-title":"Bioorganic Med. Chem. Lett."},{"issue":"7\u20138","key":"10.1016\/j.bmc.2025.118343_bb0160","first-page":"509","article-title":"Synthesis and in vitro anti-HIV activity of novel delta 2-1,2,4-oxadiazoline derivatives","volume":"49","author":"Chimirri","year":"1994","journal-title":"Farmaco"},{"key":"10.1016\/j.bmc.2025.118343_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.116612","article-title":"Synthesis and anti-HIV activity of a new isoxazole containing disubstituted 1,2,4-oxadiazoles analogs","volume":"56","author":"Kumar Kushwaha","year":"2022","journal-title":"Bioorg Med Chem"},{"issue":"15","key":"10.1016\/j.bmc.2025.118343_bb0170","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1021\/jm00041a022","article-title":"Oxadiazoles as ester bioisosteric replacements in compounds related to disoxaril. Antirhinovirus activity","volume":"37","author":"Diana","year":"1994","journal-title":"J Med Chem"},{"issue":"7","key":"10.1016\/j.bmc.2025.118343_bb0175","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1021\/acsmedchemlett.8b00134","article-title":"3-Aryl-1,2,4-oxadiazole derivatives active against human rhinovirus","volume":"9","author":"Kim","year":"2018","journal-title":"ACS Med Chem Lett"},{"issue":"1","key":"10.1016\/j.bmc.2025.118343_bb0180","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.bmcl.2011.11.013","article-title":"3-heterocyclyl quinolone inhibitors of the HCV NS5B polymerase","volume":"22","author":"Kumar","year":"2012","journal-title":"Bioorganic Med. Chem. Lett."},{"issue":"15","key":"10.1016\/j.bmc.2025.118343_bb0185","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.1016\/j.bmcl.2012.06.038","article-title":"Discovery of ITX 4520: a highly potent orally bioavailable hepatitis C virus entry inhibitor","volume":"22","author":"Mittapalli","year":"2012","journal-title":"Bioorganic Med. Chem. Lett."},{"issue":"6","key":"10.1016\/j.bmc.2025.118343_bb0190","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1002\/jhet.5570220656","article-title":"Synthesis of 5-(\u03b2-D-ribofuranosyl)-1,2,4-oxadiazole-3-carboxamide","volume":"22","author":"Hennen","year":"1985","journal-title":"J Heterocyclic Chem"},{"key":"10.1016\/j.bmc.2025.118343_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.128465","article-title":"Novel O-acylated amidoximes and substituted 1,2,4-oxadiazoles synthesised from (+)-ketopinic acid possessing potent virus-inhibiting activity against phylogenetically distinct influenza a viruses","volume":"55","author":"Chernyshov","year":"2022","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2025.118343_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116832","article-title":"Bioisosteric replacement of the carboxylic acid group in hepatitis-C virus NS5B thumb site II inhibitors: phenylalanine derivatives","volume":"279","author":"Camci","year":"2024","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118343_bb0205","series-title":"Avey Jr Alfred A, inventors; ALLERGAN INC, assignee. Method of Making Imidazole-2-thiones. US patent US 7115748 B2. patent application US 745404 A","author":"Garst","year":"2006"},{"issue":"5","key":"10.1016\/j.bmc.2025.118343_bb0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004695","article-title":"The viral polymerase inhibitor 7-Deaza-2\u2019-C-Methyladenosine is a potent inhibitor of in vitro Zika virus replication and delays disease progression in a robust mouse infection model","volume":"10","author":"Zmurko","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"10.1016\/j.bmc.2025.118343_bb0215","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1021\/acs.jmedchem.0c02258","article-title":"Design, synthesis, and biological evaluation of peptidomimetic aldehydes as broad-spectrum inhibitors against enterovirus and SARS-CoV-2","volume":"65","author":"Dai","year":"2022","journal-title":"J Med Chem"},{"issue":"2","key":"10.1016\/j.bmc.2025.118343_bb0220","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jviromet.2012.04.011","article-title":"A novel method for high-throughput screening to quantify antiviral activity against viruses that induce limited CPE","volume":"183","author":"Jochmans","year":"2012","journal-title":"J Virol Methods"},{"issue":"7324","key":"10.1016\/j.bmc.2025.118343_bb0225","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nature09555","article-title":"Glycoprotein organization of chikungunya virus particles revealed by X-ray crystallography","volume":"468","author":"Voss","year":"2010","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bmc.2025.118343_bb0230","doi-asserted-by":"crossref","first-page":"e00803","DOI":"10.1128\/mBio.00803-13","article-title":"Interaction between the hemagglutinin-neuraminidase and fusion glycoproteins of human parainfluenza virus type III regulates viral growth in vivo","volume":"4","author":"Xu","year":"2013","journal-title":"mBio"},{"key":"10.1016\/j.bmc.2025.118343_bb0235","article-title":"Chikungunya virus nsP1 interacts directly with nsP2 and modulates its ATPase activity","volume":"8(1):1045","author":"Kumar","year":"2018","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.bmc.2025.118343_bb0240","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The protein data Bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"10.1016\/j.bmc.2025.118343_bb0245","doi-asserted-by":"crossref","first-page":"W338","DOI":"10.1093\/nar\/gky356","article-title":"CABS-flex 2.0: a web server for fast simulations of flexibility of protein structures","volume":"46","author":"Kuriata","year":"2018","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"10.1016\/j.bmc.2025.118343_bb0250","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1007\/s10989-019-09978-1","article-title":"Biocomputational analysis and in silico characterization of an Angiogenic protein (RNase5) in zebrafish (Danio rerio)","volume":"26","author":"Patra","year":"2019","journal-title":"Int J Pept Res Ther"},{"issue":"2","key":"10.1016\/j.bmc.2025.118343_bb0255","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J Comput Chem"},{"issue":"2","key":"10.1016\/j.bmc.2025.118343_bb0260","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/bioinformatics\/18.2.315","article-title":"Models@home: distributed computing in bioinformatics using a screensaver based approach","volume":"18","author":"Krieger","year":"2002","journal-title":"Bioinformatics"},{"key":"10.1016\/j.bmc.2025.118343_bb0265","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/978-1-61779-465-0_25","article-title":"Assignment of protonation states in proteins and ligands: combining pKa prediction with hydrogen bonding network optimization","volume":"819","author":"Krieger","year":"2012","journal-title":"Methods Mol Biol"},{"issue":"4","key":"10.1016\/j.bmc.2025.118343_bb0270","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.jmgm.2006.02.009","article-title":"Fast empirical pKa prediction by Ewald summation","volume":"25","author":"Krieger","year":"2006","journal-title":"J Mol Graph Model"},{"key":"10.1016\/j.bmc.2025.118343_bb0275","series-title":"WaPA. AMBER 14","author":"VB","year":"2014"},{"issue":"9","key":"10.1016\/j.bmc.2025.118343_bb0280","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J Comput Chem"},{"issue":"16","key":"10.1016\/j.bmc.2025.118343_bb0285","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/jcc.10128","article-title":"Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation","volume":"23","author":"Jakalian","year":"2002","journal-title":"J Comput Chem"},{"issue":"3","key":"10.1016\/j.bmc.2025.118343_bb0290","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/prot.21123","article-title":"Comparison of multiple Amber force fields and development of improved protein backbone parameters","volume":"65","author":"Hornak","year":"2006","journal-title":"Proteins"},{"issue":"19","key":"10.1016\/j.bmc.2025.118343_bb0295","doi-asserted-by":"crossref","first-page":"8577","DOI":"10.1063\/1.470117","article-title":"A smooth particle mesh Ewald method","volume":"103","author":"Essmann","year":"1995","journal-title":"J Chem Phys"},{"issue":"15","key":"10.1016\/j.bmc.2025.118343_bb0300","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/prot.10104","article-title":"Increasing the precision of comparative models with YASARA NOVA--a self-parameterizing force field","volume":"47","author":"Krieger","year":"2002","journal-title":"Proteins"},{"issue":"8","key":"10.1016\/j.bmc.2025.118343_bb0305","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1038\/s41564-024-01722-w","article-title":"Functional and structural basis of human parainfluenza virus type 3 neutralization with human monoclonal antibodies","volume":"9","author":"Suryadevara","year":"2024","journal-title":"Nat Microbiol"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089625002846?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089625002846?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T08:33:08Z","timestamp":1778574788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089625002846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":61,"alternative-id":["S0968089625002846"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2025.118343","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiviral activities of phenylalanine derivatives carrying carboxylic acid bioisosteres against chikungunya and parainfluenza virus type 3","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2025.118343","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118343"}}